Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Cheng D, Luo Z, Ning W, Heath SL, Gisslen M, Price RW, Adekunle R, Salman T, Johnson D, McKinnon JE, Ndhlovu LC, Hossain R, Hu W, Jiang W. Systemic translocation of Staphylococcus aureus promotes autoimmunity: implications in autoantibody-mediated poor immune reconstitution from antiretroviral therapy in HIV. J Virol. 2026 May 19; 100(5):e0196525.
-
Al-Rabadi LF, Storey AJ, Abuelsamen T, Takayama S, Walker PD, Nwaduru CE, Kawalit I, Zimmerman M, Hoxha E, Borza DB, Beck L, Larsen CP, Caza TN. Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older. Kidney Int. 2026 Jun; 109(6):1318-1323.
-
Kuang H, Wang BN, Jia XY, Cui Z, Yu XJ, Jiang N, Borza DB, Zhao MH. Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease. Nephrol Dial Transplant. 2025 Dec 23; 41(1):55-66.
-
Alexander BN, Kim S, Wells KL, Hunter MJ, Toole KP, Wemlinger SM, Regan DP, Getahun A, Smith MJ. Deletion of Ptpn2 in B cells promotes autoimmunity via TLR and JAK/STAT signaling. JCI Insight. 2025 Dec 22; 10(24).
-
Qiu C, Wang X, Francia G, Casiano CA, Zhang JY. A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection. Br J Cancer. 2026 Feb; 134(3):493-503.
-
Starkey SY, Maurer K, Bassett A, McDonald McGinn DM, Sullivan KE. Autoantibodies in patients with 22q11.2 deletion syndrome and psychosis. J Allergy Clin Immunol. 2025 Oct; 156(4):1103-1110.
-
Caza TN, Arivett BA, Hassen SI, Al-Rabadi LF, Takayama S, Ibrahim A, Larsen CP, Borza DB. Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathy. Kidney Int. 2025 Sep; 108(3):427-432.
-
Nicholas CA, Tensun FA, Evans SA, Toole KP, Prendergast JE, Broncucia H, Hesselberth JR, Gottlieb PA, Wells KL, Smith MJ. Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes. Cell Rep. 2025 Apr 22; 44(4):115425.
-
Bowler SA, Premeaux TA, Ratzan L, Friday C, Gianella S, Landay AL, Ndhlovu LC. Plasma anti-CD4 IgG levels are associated with poor immune recovery in people with HIV initiating antiretroviral therapy. AIDS. 2025 Feb 01; 39(2):208-210.
-
Gallo PM, Chain RW, Xu J, Whiteman LM, Palladino A, Caricchio R, Costa-Reis P, Sullivan KE, Gallucci S. EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon a-accelerated murine lupus. Int Immunopharmacol. 2024 Oct 25; 140:112692.